Sarah May brings a unique perspective to her work with Injury Lawyer News. After over ten years of practicing law, she is now focused on raising awareness about ongoing pharmaceutical litigation.
Lawsuit filings alleging serious side effects and injuries stemming from the use of testosterone supplements such as Axiron, Androgel and Testim continue to accumulate in courts nationwide, with the tally of federal cases nearly reaching 2,000. Testosterone injury lawsuits have been centralized into a multidstrict litigation... Read More
In yet another key development in the progress of well over a thousand federal Mirena IUD lawsuits, Judge Cathy Seibel of the U.S. District Court in the Southern District of New York has recently identified five cases which will comprise a second round of bellwether... Read More
A Bergen County mother and father have filed suit in the United States District Court for the District of Jersey in what may be the very latest in the growing tally of lawsuits stemming from the use of anti-nausea medication Zofran (ondansetron) by pregnant women... Read More
A birth injury lawsuit has been filed in the U.S. District Court for the Eastern District of Virginia against the federal government pursuant to the Federal Tort Claims Act. The complaint stems from negligence during a vacuum-assisted delivery alleged to have occurred at Fort Belvoir Community Hospital, which... Read More
The U.S. District Court for the Eastern District of Arkansas is now the scene of yet another Zofran lawsuit, adding to the growing tally of birth defect complaints being filed across the country. On May 21, a couple residing in that state formally alleged that... Read More
According to a recently published research study, popular anticoagulant drugs Xarelto and Pradaxa may pose a heightened risk of serious gastrointestinal bleeding in patients who choose them instead of more traditional blood thinning medications such as warfarin. The study, undertaken by researchers from Johns Hopkins... Read More
Two new Zofran lawsuits allege that GlaxoSmithKline (GSK) engaged in fraudulent marketing practices relating to use of the medication as an off-label treatment for morning sickness. The plaintiffs, filing in Texas and Massachusetts federal courts respectively, argue that the pharmaceutical company misled the public about... Read More
As questions are raised over the connection, if any, between use of anti-nausea drug Zofran (ondansetron) by pregnant women and an increased risk of birth defects, new research indicates that the medication does in fact cross the placenta to reach the developing fetus and likely remains with... Read More
